Presence in Indian Pharmaceutical Market| Emcure Pharmaceuticals

The Indian Pharmaceutical Market (IPM) is the largest business unit for Emcure Pharmaceuticals, which is operated under Emcure India and Zuventus Healthcare

Despite being a late entrant in the market, Emcure has leapfrogged its peers and established itself as a leading player with a niche product basket and positioning. Emcure achieved a major milestone in April 2021 as it was ranked as the 9th largest company in the Indian pharma market (AICOD-AWACS April-21).

4x

of industry growth
in FY21

4,500+

Medical
Representatives

3.5L

doctors

The product basket of Emcure Pharmaceuticals which has a strong chronic and sub-chronic focus, covers all the major therapies and is the market leader in areas such as women's health, blood-related, HIV, anti-infectives, cardiac and vitamins.

Emcure Pharmaceutical operates across a wide scope of areas

Gynaecological

Industry leader addressing women’s health issues

OROFER-XT

OROFER-FCM

Feronia XT

FERIUM FCM

55% of women in India are anemic, Emcure’s mission is to make India anemia free
Emcure is associated with the launch of Ferric carboxymaltose & Ferrous Ascorbate for the first time in India
Presence in all key segments: Iron Deficiency, Pregnancy care, Dysmenorrhea, Heamostats, Infertility & Feminine Hygiene

Cardiology

Pioneers in Chirality

ASOMEX

ENOXARIN

ELAXIM

ESLO

METPURE XL

Deep routed presence in Hypertension, Anti-Thrombotic and lipid regulators

Antivirals

Leaders in the global fight against HIV

INSTGRA

SPEGRA

VIROPIL

Multiple first time introductions in India
Committed to HIV care

Vitamins

Supplementing Health

ZU-C 500

HOSIT

BEVON

VITANOVA D3

Emcure has a wide range of products available under oral, liquid and injectables

Pain/ Analgesics

Chirally Pure Brand

INFEN

FITJOINT MAX

MYOTOP

EMANZEN D

PROXYM

Emanzen D is developed with double enteric coating cold technology that ensures rapid pain relief, powerful anti-inflammatory response while being gentle to the gastro intestinal tract

Anti- neoplastic

Strong Biologics Portfolio

EMGRAST-M

PEGEX

HAMSYL

OXA

XGRAST

Emcure is one of the fastest growing company in this highly specialized therapy

Diabetes

Emerging player in this fight against chronic condition

Vylda-M

Vylda

Anti-infective

Largest portfolio with best-in-class medicines

TAZOTUM

ZOSTUM

MEROTEC

AUGPEN

Zostum is one of 7 brands listed in the top 300 brands of IPM

Respiratory

Differentiated portfolio aiding growth

MAXTRA

BROPHYLE

SOVENTUS

CNS

Bringing innovation for stroke

TENECTASE

Tenectase is a pioneering brand used in the treatment of Acute ischemic stroke
Emerging focus area for Emcure driven by its biologics portfolio along with other formulations

Nephrology

DARBECURE

DYNULTA

SEVCAR

MOFILET

VINGRAF

Dynulta, the only Sucroferric Oxyhydroxide available in the country in this category

Our business